Delayed
Hong Kong S.E.
08:22:33 30/04/2024 am IST
|
5-day change
|
1st Jan Change
|
0.87
HKD
|
-3.33%
|
|
+1.16%
|
-11.22%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
451.4
|
315.2
|
335.3
|
244.3
|
211.1
|
536.5
|
Enterprise Value (EV)
1 |
407.2
|
285.1
|
327.6
|
250.3
|
220.6
|
524.8
|
P/E ratio
|
-12.5
x
|
-13.5
x
|
-9.1
x
|
-31.1
x
|
-17.2
x
|
-11.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
18.6
x
|
9.8
x
|
7.43
x
|
2.78
x
|
1.97
x
|
7.02
x
|
EV / Revenue
|
16.8
x
|
8.86
x
|
7.25
x
|
2.85
x
|
2.06
x
|
6.87
x
|
EV / EBITDA
|
-12.6
x
|
-14.3
x
|
-12.9
x
|
-26.1
x
|
-26.3
x
|
-51.9
x
|
EV / FCF
|
-18.4
x
|
-4.92
x
|
-127
x
|
-14.9
x
|
6.59
x
|
1,168
x
|
FCF Yield
|
-5.45%
|
-20.3%
|
-0.79%
|
-6.71%
|
15.2%
|
0.09%
|
Price to Book
|
2.8
x
|
2.42
x
|
3.46
x
|
2.57
x
|
2.65
x
|
6.12
x
|
Nbr of stocks (in thousands)
|
3,63,995
|
4,09,395
|
4,13,995
|
4,13,995
|
4,13,995
|
4,78,995
|
Reference price
2 |
1.240
|
0.7700
|
0.8100
|
0.5900
|
0.5100
|
1.120
|
Announcement Date
|
30/07/18
|
31/07/19
|
29/07/20
|
30/07/21
|
31/07/22
|
30/07/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
24.25
|
32.18
|
45.16
|
87.89
|
107
|
76.41
|
EBITDA
1 |
-32.24
|
-19.93
|
-25.42
|
-9.591
|
-8.378
|
-10.11
|
EBIT
1 |
-33.67
|
-21.6
|
-27.37
|
-12.18
|
-11.3
|
-12.82
|
Operating Margin
|
-138.85%
|
-67.13%
|
-60.6%
|
-13.86%
|
-10.56%
|
-16.78%
|
Earnings before Tax (EBT)
1 |
-36.72
|
-19.92
|
-34.34
|
-5.331
|
-8.709
|
-39.38
|
Net income
1 |
-39.25
|
-23.08
|
-36.68
|
-7.744
|
-12.2
|
-42.05
|
Net margin
|
-161.86%
|
-71.72%
|
-81.22%
|
-8.81%
|
-11.4%
|
-55.02%
|
EPS
2 |
-0.0990
|
-0.0570
|
-0.0890
|
-0.0190
|
-0.0296
|
-0.0986
|
Free Cash Flow
1 |
-22.19
|
-57.92
|
-2.575
|
-16.8
|
33.47
|
0.4494
|
FCF margin
|
-91.5%
|
-179.96%
|
-5.7%
|
-19.12%
|
31.27%
|
0.59%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/07/18
|
31/07/19
|
29/07/20
|
30/07/21
|
31/07/22
|
30/07/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
6.07
|
9.43
|
-
|
Net Cash position
1 |
44.2
|
30.2
|
7.73
|
-
|
-
|
11.7
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-0.633
x
|
-1.126
x
|
-
|
Free Cash Flow
1 |
-22.2
|
-57.9
|
-2.57
|
-16.8
|
33.5
|
0.45
|
ROE (net income / shareholders' equity)
|
-29%
|
-15.7%
|
-30.7%
|
-6.54%
|
-9.85%
|
-44.2%
|
ROA (Net income/ Total Assets)
|
-10.6%
|
-6.13%
|
-8.3%
|
-3.67%
|
-3.18%
|
-3.58%
|
Assets
1 |
368.7
|
376.5
|
441.8
|
210.9
|
383.5
|
1,173
|
Book Value Per Share
2 |
0.4400
|
0.3200
|
0.2300
|
0.2300
|
0.1900
|
0.1800
|
Cash Flow per Share
2 |
0.1100
|
0.0700
|
0.0200
|
0.0100
|
0.0200
|
0.0200
|
Capex
1 |
0.26
|
-
|
0.43
|
1.84
|
0.8
|
1.37
|
Capex / Sales
|
1.06%
|
-
|
0.95%
|
2.09%
|
0.74%
|
1.79%
|
Announcement Date
|
30/07/18
|
31/07/19
|
29/07/20
|
30/07/21
|
31/07/22
|
30/07/23
|
|
1st Jan change
|
Capi.
|
---|
| -11.22% | 53.85M | | -3.54% | 9.4B | | +31.91% | 1.92B | | -2.80% | 1.39B | | -5.84% | 1.18B | | -16.69% | 856M | | +0.67% | 470M | | +3.39% | 437M | | -49.63% | 360M | | -22.36% | 333M |
Medical Equipment Wholesale
|